| J9271 | Injection, pembrolizumab, 1 mg | 17,800 | $40 | $765.4K |
| J0897 | Injection, denosumab, 1 mg | 10,920 | $20 | $196.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 880 | $90 | $82.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 270 | $100 | $26.4K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 12,280 | $1 | $24.6K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 24,000 | $1 | $24K |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 80 | $280 | $23K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 350 | $60 | $21.9K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 50 | $350 | $15.7K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 110 | $120 | $13.1K |